POMOZA Trademark

Trademark Overview

On Thursday, March 31, 2016, a trademark application was filed for POMOZA with the United States Patent and Trademark Office. The USPTO has given the POMOZA trademark a serial number of 86959628. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 15, 2023. This trademark is owned by Celgene Corporation. The POMOZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
pomoza

General Information

Serial Number86959628
Word MarkPOMOZA
Filing DateThursday, March 31, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 15, 2023
Registration Number5211889
Registration DateTuesday, May 30, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Translation of Words in MarkThe wording "POMOZA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, December 15, 2023CANCELLED SEC. 8 (6-YR)
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, May 30, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 30, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, October 11, 2016Sec. 1(B) CLAIM DELETED
Tuesday, October 11, 2016WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Monday, October 10, 2016TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, September 27, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2016PUBLISHED FOR OPPOSITION
Wednesday, September 7, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 19, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 11, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 11, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 11, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 5, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 11, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 11, 2016NON-FINAL ACTION E-MAILED
Wednesday, May 11, 2016NON-FINAL ACTION WRITTEN
Wednesday, May 11, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 11, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 6, 2016ASSIGNED TO LIE
Friday, April 22, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 22, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 22, 2016NON-FINAL ACTION E-MAILED
Friday, April 22, 2016NON-FINAL ACTION WRITTEN
Thursday, April 21, 2016ASSIGNED TO EXAMINER
Tuesday, April 5, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 4, 2016NEW APPLICATION ENTERED

Related Keywords

pomoza pharmaceutical disease preparations namely diseases skin cytokine musculoskeletal inhibitory immune